| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年三季报 | 2023年中报 | |
|---|---|---|---|---|---|---|
| 营业收入(元) | ||||||
| 哌嗪系列(元) | 177,344,183.75 | 405,910,313.58 | 191,846,085.20 | 548,546,083.14 | 436,253,669.70 | 320,297,100.00 |
| 酰胺系列(元) | 24,943,986.08 | 32,427,870.75 | 13,651,013.67 | 25,207,218.17 | 19,494,781.79 | 14,266,900.00 |
| 其他(元) | 16,088,217.26 | 29,801,049.08 | 12,846,002.96 | 56,491,077.53 | 46,233,310.95 | 28,782,500.00 |
| 营业成本(元) | ||||||
| 哌嗪系列(元) | 122,017,986.88 | 276,922,529.92 | 132,117,311.19 | 352,413,180.22 | - | 202,345,200.00 |
| 酰胺系列(元) | 12,054,543.04 | - | - | - | - | 6,250,600.00 |
| 其他(元) | 16,296,919.12 | - | - | - | - | 24,985,400.00 |
| 毛利(元) | ||||||
| 哌嗪系列(元) | 55,326,196.87 | 128,987,783.66 | 59,728,774.01 | 196,132,902.92 | - | 117,951,900.00 |
| 酰胺系列(元) | 12,889,443.04 | - | - | - | - | 8,016,300.00 |
| 其他(元) | -208,701.86 | - | - | - | - | 3,797,100.00 |
| 毛利率(%) | ||||||
| 哌嗪系列(%) | 31.20 | 31.78 | 31.13 | 35.76 | - | 36.83 |
| 酰胺系列(%) | 51.67 | - | - | - | - | 56.19 |
| 其他(%) | -1.30 | - | - | - | - | 13.19 |
| 收入构成(%) | ||||||
| 哌嗪系列(%) | 81.21 | 86.71 | 87.86 | 87.04 | 86.91 | 88.15 |
| 酰胺系列(%) | 11.42 | 6.93 | 6.25 | 4.00 | 3.88 | 3.93 |
| 其他(%) | 7.37 | 6.37 | 5.88 | 8.96 | 9.21 | 7.92 |
| 毛利构成(%) | ||||||
| 哌嗪系列(%) | 81.35 | 100.00 | 100.00 | 100.00 | - | 90.90 |
| 酰胺系列(%) | 18.95 | 0.00 | 0.00 | 0.00 | - | 6.18 |
| 其他(%) | -0.31 | 0.00 | 0.00 | 0.00 | - | 2.93 |